Manuscripts
Showing 1576 manuscripts.
Model-informed once-daily dosing strategy for bedaquiline and delamanid in children, adolescents and adults with tuberculosis
Citation
Yu-Jou Lin, Louvina E. van der Laan, Mats O. Karlsson, Anthony J. Garcia-Prats, Anneke C. Hesseling, Elin M. Svensson. Model-informed once-daily dosing strategy for bedaquiline and delamanid in children, adolescents and adults with tuberculosis. Clinical Pharmacology & Therapeutics. 2025. 117: 1292-1302. PMID: 39731394Year
2025
Journal
Clinical Pharmacology & Therapeutics
Study
IMPAACT 2020
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in HIV-1-Exposed Newborn Infant
Citation
Coleen K. Cunningham, Elizabeth J. McFarland, Petronella Muresan, Edmund V. Capparelli, Charlotte Perlowski, Benjamin Johnston, Frederic Bone, Lynette Purdue, Dwight E. Yin, Jack Moye, Hans M.L. Spiegel, Sai Majji, Gerhard B. Theron, Hilda A. Mujuru, Murli Purswani, Grace Alvarez, Jaime G. Deville, Carrie Chambers, Emily Brown, Paul A. Harding, Nicole H. Tobin, Kwang Low, Lucio Gama, IMPAACT P1112 Team. Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in HIV-1-Exposed Newborn Infant. Journal of the Pediatric Infectious Diseases Society. 2025. 14: piaf002. PMID: 39821046Year
2025
Journal
Journal of the Pediatric Infectious Diseases Society
Study
P1112
Efficacy, safety, and tolerability of dispersible and immediate release abacavir/dolutegravir/lamivudine tablets in children with HIV: IMPAACT 2019 week 48 results
Citation
Helena Rabie, Dwight E. Yin, Shawn Ward, Yasha Rani, Lauren Ziemba, Kristina M. Brooks, Tim R. Cressey, Gaerolwe R. Masheto, Haseena Cassim, Jaime G. Deville, Ponego L. Ponatshego, Faeezah Patel, Linda Aurpibul, Shaun L. Barnabas, Iris Mustich, Anne Coletti, Barbara Heckman, Chelsea Krotje, Ellen Townley, Jack Moye, Sai Majji, Edward P. Acosta, Kevin Ryan, Hardik Chandasana, Cynthia H. Brothers, Ann M. Buchanan, Patricia M. Flynn, IMPAACT 2019 Study Team. Efficacy, safety, and tolerability of dispersible and immediate release abacavir/dolutegravir/lamivudine tablets in children with HIV: IMPAACT 2019 week 48 results. 2025. PMID: 40440679Year
2025
Study
IMPAACT 2019
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV
Citation
Rupak SHIVAKOTI, Mark J. Giganti, Michael M Lederman, Rachel Ketchum, Sean S. Brummel, Daniela Moisi, Allen T Matubu, Sufia Dadabhai, Dhayendre Moodley, Avy Violari, Lameck Chinula, Maxensia Owor, Amita Gupta, Taha E. Taha, Patricia M. Flynn, Judith S. Currier, Mary Glenn Fowler, PROMISE Study Team. Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV. AIDS. 2025. PMID: 40476693Year
2025
Journal
AIDS
Study
1077BF, 1077FF
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s study
Citation
Marije Van Schalkwyk, Adrie Bekker, Eric Decloedt, Jiajia Wang, Gerhard B. Theron, Mark F. Cotton, Ahizechukwu C. Eke, Tim R. Cressey, Deo Wabwire, David E. Shapiro, Kira Bacon, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chakhtoura, Kittipong Rungruengthanakit, Lubbe Wiesner, Edmund V. Capparelli, Alice M. Stek, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s study. Journal Antimicrobial Agents and Chemotherapy. 2025. 69: e0005225. PMID: 40741959Year
2025
Journal
Journal Antimicrobial Agents and Chemotherapy
Study
P1026S
Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
Citation
Ethan Ashby, Genevieve Fouda, Holly Janes, Bo Zhang, Youyi Fong. Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants. Statistics In Medicine. 2025. 44: e70142. PMID: 40492758Year
2025
Journal
Statistics In Medicine
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV
Citation
Nicole H. Tobin, Sarah Brooker, Fan Li, Yoninah S. Cramer, Susan Rosenkranz, Robert W. Coombs, Susan E. Cohn, Carmen Zorrilla, Laura Moran, Baiba Berzins, Kimberly K. Scarsi, Catherine Godfrey, Grace M. Aldrovandi, ACTG 5316 Team. Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. Journal of Infectious Diseases. 2025. 231: 583-594. PMID: 39479902Year
2025
Journal
Journal of Infectious Diseases
Altered milk tryptophan and tryptophan metabolites and health of children born to women with HIV
Citation
Nicole H. Tobin, Fan Li, Wentao Zhu, Kathie G. Ferbas, John W. Sleasman, Daniel Raftery, Louise Kuhn, Grace M. Aldrovandi. Altered milk tryptophan and tryptophan metabolites and health of children born to women with HIV. Nature Communications. 2025. 16: 9437. PMID: 41152239Year
2025
Journal
Nature Communications
Mixing of Tecovirimat in Water to Support Oral Dosing of Infants and Children With Mpox
Citation
Z. Wei, Kristina Brooks, Sharon Nachman, Grace Aldrovandi, Timothy Wilkin, William Fischer, Jennifer Kiser, Jason Zucker. Mixing of Tecovirimat in Water to Support Oral Dosing of Infants and Children With Mpox. 2025. PMID: 39953939Year
2025
Study
A5418
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens
Citation
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, Matthew E. Barnhart, Adrie Bekker, Katerina Chapman, Coleen K. Cunningham, Patricia E. Fast, Genevieve G. Fouda, Kenneth A. Freedberg, Ameena Goga, Lusine R. Ghazaryan, Valériane Leroy, Carlyn Mann, Margaret M. McCluskey, Elizabeth J. McFarland, Vincent Muturi-Kioi, Sallie R. Permar, Roger Shapiro, Devin Sok, Lynda Stranix-Chibanda, Milton C. Weinstein, Andrea L. Ciaranello, Caitlin M. Dugdale. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. PLoS One. 2025. 20: e0318940. PMID: 40106399Year
2025
Journal
PLoS One
Study
P1112